Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print May 14, 2003.
Biol Reprod 2003, 10.1095/biolreprod.103.016287
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/3/843    most recent
biolreprod.103.016287v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, K.
Right arrow Articles by Spencer, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, K.
Right arrow Articles by Spencer, T. E.
Agricola
Right arrow Articles by Hayashi, K.
Right arrow Articles by Spencer, T. E.
BIOLOGY OF REPRODUCTION 69, 843–850 (2003)
DOI: 10.1095/biolreprod.103.016287
© 2003 by the Society for the Study of Reproduction, Inc.


Female Reproductive Tract

The Activin-Follistatin System in the Neonatal Ovine Uterus1

Kanako Hayashi, Karen D. Carpenter, C. Allison Gray, and Thomas E. Spencer2

Center for Animal Biotechnology and Genomics and Department of Animal Science, Texas A&M University, College Station, Texas 77843-2471


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Uterine gland development or adenogenesis in the neonatal ovine uterus involves budding and tubulogenesis followed by coiling and branching morphogenesis of the glandular epithelium (GE) from the luminal epithelium (LE) between birth (Postnatal Day [PND] 0) and PND 56. Activins, which are members of the transforming growth factor ß superfamily, and follistatin, an inhibitor of activins, regulate epithelial branching morphogenesis in other organs. The objective of the present study was to determine effects of postnatal age on expression of follistatin, inhibin {alpha} subunit, ßA subunit, ßB subunit, activin receptor (ActR) type IA, ActRIB, and ActRII in the developing ovine uterus. Ewes were ovariohysterectomized on PND 0, 7, 14, 21, 28, 35, 42, 49, or 56. The uterus was analyzed by in situ hybridization and immunohistochemistry. Neither inhibin {alpha} subunit mRNA or protein was detected in the neonatal uterus. Expression of ßA and ßB subunits was detected predominantly in the endometrial LE and GE and myometrium between PND 0 and PND 56. In all uterine cell types, ActRIA, ActRIB, and ActRII were expressed, with the highest levels observed in the endometrial LE and GE and myometrium. Between PND 0 and PND 14, follistatin was detected in all uterine cell types. However, between PND 21 and PND 56, follistatin was only detected in the stroma and myometrium and not in the developing GE. Collectively, the present results indicate that components of the activin-follistatin system are expressed in the developing neonatal ovine uterus and are potential regulators of endometrial gland morphogenesis.

activin, developmental biology, follistatin, inhibin, uterus


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Postnatal uterine morphogenesis in the ewe involves the emergence, proliferation, and differentiation of endometrial glands, specification of intercaruncular stroma, development of endometrial folds, and to a lesser extent, growth of endometrial caruncular areas and the myometrium [15]. Uterine gland development or adenogenesis is initiated between Postnatal Day (PND) 1 and PND 7, when shallow epithelial invaginations appear along the luminal epithelium (LE) in presumptive intercaruncular areas. Between PNDs 7 and 14, the nascent glandular epithelium (GE) buds proliferate, migrate into the stroma, and form tubules or ducts that begin to coil and branch at the tips by PND 21. After PND 21, uterine adenogenesis primarily involves branching morphogenesis of tubular and coiled endometrial glands in the stratum spongiosum adjacent to the inner circular layer of the myometrium. By PND 56, uterine gland morphogenesis is essentially complete, because the aglandular caruncular and glandular intercaruncular endometrial areas appear to be similar histoarchitecturally to those of the adult uterus [1]. Final maturation and growth of the ovine uterus may not occur until puberty [6] and during the first pregnancy, which involves extensive hyperplasia and hypertrophy of the endometrial glands [7, 8]. To our knowledge, the hormonal, cellular, and molecular mechanisms governing postnatal endometrial adenogenesis have not been well investigated in any species [9, 10].

Activins and inhibins are members of the transforming growth factor (TGF) ß superfamily and regulate growth and differentiation of many branched epitheliomesenchymal organs via autocrine, paracrine, and perhaps, endocrine mechanisms [1122]. Activins and inhibins are dimeric proteins [23, 24]. Activin consists of two ß subunits, ßA and ßB, that homodimerize or heterodimerize to form activin A (ßA:ßA), activin B (ßB:ßB), or activin AB (ßA:ßB). Inhibin consists of an {alpha} subunit that heterodimerizes with an activin ß subunit to form either inhibin A ({alpha}:ßA) or inhibin B ({alpha}:ßB). The biological activity of activins is mediated by receptor complexes, consisting of activin receptor (ActR) type IA or ActRIB and ActRII [2325]. One of the key features distinguishing the effects of activins from those of TGFß is that binding of activins to their receptors can be inhibited by follistatin and inhibin {alpha} subunit [2628]. Follistatin binds to activins with high affinity and neutralizes their activity [27, 29, 30]. Originally isolated from ovarian follicular fluid, follistatin inhibits pituitary FSH secretion [24, 31].

The activin-follistatin system is a complex regulatory system controlling cellular proliferation and differentiation in many epitheliomesenchymal organs, including the kidney, prostate, mammary gland, lung, pancreas, and salivary gland [1122]. Our working hypothesis is that the activin-follistatin system exists in the uterus and, along with potential endocrine effects of hormones of the activin-follistatin system from the ovary, regulates endometrial gland branching morphogenesis in the neonatal ovine uterus. As a first step in testing this hypothesis, expression of the major components of the activin-follistatin system (follistatin, ßA subunit, ßB subunit, ActRIA, ActRIB, ActRII, and inhibin {alpha} subunit) was studied in the uterus of the neonatal ewe.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Experimental Design and Tissue Collection

The University Laboratory Animal Care and Use Committee of Texas A&M University approved all experimental and surgical procedures. Cross-bred Suffolk ewes were mated to Suffolk rams between September and November 2000. Pregnant ewes were maintained according to normal husbandry practices. Ewes included in the following experiments were born between January and May 2001. Ewes (n = 45) were assigned randomly at birth (PND 0) to be hysterectomized on PND 0 (n = 6), 7 (n = 4), 14 (n = 5), 21 (n = 5), 28 (n = 5), 35 (n = 5), 42 (n = 5), 49 (n = 5), or 56 (n = 5). The entire reproductive tract (uterus and ovary) was excised, and the uterus was trimmed free of the broad ligament, oviduct, and cervix. Sections from the middle of each uterine horn (thickness, ~1 cm) and half of each ovary were fixed in 4% (w/v) paraformaldehyde in PBS (pH 7.2). After 24 h, fixed tissues were changed to 70% (v/v) ethanol and then embedded in Paraplast Plus (Oxford Labware, St. Louis, MO). The remainder of the ovary and uterus was frozen in liquid nitrogen and stored at -80°C. The ovaries were analyzed in a companion study [32].

In Situ Hybridization

Partial cDNAs for follistatin, inhibin {alpha} subunit, ßA subunit, ßB subunit, ActRIA, ActRIB, and ActRII mRNAs were generated by reverse transcription-polymerase chain reaction (RT-PCR) using total RNA isolated from the neonatal ovary or uterus as described previously [1]. Primer and annealing temperatures used for PCR are summarized in Table 1. The amplified PCR products were subcloned into the pCRII cloning vector using a T/A Cloning Kit (Invitrogen Life Technologies, Carlsbad, CA) and sequenced in both directions using an ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI PRISM automated DNA sequencer (Perkin-Elmer Applied Biosystems, Foster City, CA) to confirm identity.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Summary of PCR primer sequences and expected cDNA sizes

Expression of mRNAs in uterine tissues was determined by in situ hybridization as described previously [33]. Briefly, deparaffinized, rehydrated, and deproteinated cross-sections (thickness, 5 µm) of the uterine horns from each ewe were hybridized with radiolabeled sense or antisense cRNA probes generated from linearized plasmid templates using in vitro transcription with [35S-{alpha}]UTP. After hybridization, washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic emulsion (Eastman Kodak, Rochester, NY), stored at 4°C for 2–28 days, and developed in Kodak D-19 developer. Slides were then counterstained with Gills modified hematoxylin (Stat Lab, Lewisville, TX), dehydrated through a graded series of alcohol to xylene, and protected with a coverslip. Images of representative fields of sections hybridized with antisense or sense cRNAs were recorded under bright- or dark-field illumination with a Nikon Eclipse 1000 photomicroscope (Nikon Instruments, Inc., Lewisville, TX) fitted with a Nikon DXM1200 digital camera using constant image acquisition parameters to ensure accurate comparison.

Immunohistochemistry

Expression of immunoreactive follistatin, inhibin {alpha} subunit, ßA subunit, ßB subunit, ActRIA, ActRIB, and ActRIIA/B protein was detected in cross-sections (thickness, 5 µm) of the uterine horns from each ewe using specific antibodies and a Super ABC Mouse/Rat Immunoglobulin G (IgG) Kit (Biomeda, Foster City, CA) as described previously [34]. Mouse anti-human monoclonal antibody to follistatin (catalog no. MAB669), ActRIA (catalog no. MAB637), ActRIB (catalog no. MAB222), and ActRIIA/B (catalog no. MAB3391) were from R&D Systems, Inc. (Minneapolis, MN). Mouse anti-human antibody to inhibin {alpha} subunit (catalog no. MCA951S), ßA subunit (catalog no. MCA950S), and ßB subunit (catalog no. MCA1661) were purchased from Serotec, Inc. (Raleigh, NC). The working antibody concentration employed for immunohistochemistry was 6.7 µg/ml for follistatin, 400 ng/ml for inhibin {alpha} subunit, 200 ng/ml for ßA subunit, 200 ng/ml for ßB subunit, 1 µg/ml for ActRIA, 2 µg/ml for ActRIB, and 1 µg/ml for ActRII. Negative controls were performed in which the primary antibody was substituted with the same concentration of normal mouse IgG from Sigma Chemical Co. (St. Louis, MO). Antigen retrieval using boiling citrate buffer was performed for all antibodies according to the manufacturer's recommendations. The chromogen used for peroxidase localization was 3,3'-diaminobenzidine tetrahydrochloride from Sigma. Tissue sections from both uterine horns of each ewe were processed as sets within an experiment.

As described previously [3], relative staining intensity for immunoreactive protein expression was assessed visually in uterine sections (n = 2 per horn) from each ewe by two independent observers and scored as follows: absent (-; i.e., no staining above IgG control), weak (+), moderate (++), or strong (+++). The scores from the two observers were averaged. If histologically discernable, intercaruncular endometrial tissues (including LE, stroma, and GE) and caruncular endometrial tissues (including LE and stroma) and myometrium were scored. The GE was separated into shallow (stratum compactum) and deep (stratum spongiosum). Images of representative fields of sections probed with primary antibodies or IgG were recorded using a Nikon Eclipse 1000 photomicroscope fitted with a Nikon DXM1200 digital camera using constant image acquisition parameters to ensure accurate comparisons.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cloning of Partial cDNAs for the Ovine Follistatin-Activin System

Partial cDNAs corresponding to inhibin {alpha} subunit, ßA subunit, ßB subunit, ActRIA, ActRIB, and ActRII were generated by RT-PCR using total RNA from the neonatal ovine ovary or uterus and specific primers (Table 1). Analysis of sequences of the partial cDNAs verified their identity based on homology to sequences in GenBank of ovine or bovine origin (data not shown).

Inhibin {alpha} Subunit, ßA Subunit, and ßB Subunit

Representative photomicrographs of in situ hybridization and immunohistochemistry results are presented in Figure 1. Patterns of immunoreactive protein expression are summarized in Table 2.



View larger version (105K):
[in this window]
[in a new window]
 
FIG. 1. Expression of inhibin {alpha}- and ß subunits in the neonatal ovine uterus. In situ hybridization and immunohistochemical analysis of ßA subunit (A) and ßB subunit (B) in the uterus. In each panel portion, representative photomicrographs of in situ hybridization results are presented in bright-field and dark-field illumination (left). Melanocytes in the endometrium appear white in the dark-field images and black in bright-field images, but they do not express subunit mRNA. Representative photomicrographs of immunohistochemical results are presented for the upper and lower portions of the uterine wall (right). As a negative control, mouse IgG (mIgG) was substituted for the primary antibodies. M, Myometrium; S, stroma. Bars = 50 µm


View this table:
[in this window]
[in a new window]
 
TABLE 2. Distribution and relative abundance of immunoreactive ßA subunit and ßB subunit protein in the neonatal uterus.a

Inhibin {alpha} subunit In the uterus, neither inhibin {alpha} subunit mRNA or protein were detected by in situ hybridization and immunohistochemical analyses between PND 0 and PND 56 as compared to negative controls (data not shown). Although not detected in the uterus, abundant expression of inhibin {alpha} subunit mRNA and protein was detected in granulosa and cumulus cells of antral follicles in the ovaries of the neonatal ewes in the present study (data not shown).

ßA subunit In the developing neonatal uterus, ßA subunit mRNA and protein were detected in all endometrial cell types but were most abundant in the endometrial LE and developing GE (Fig. 1A and Table 2). In the myometrium, ßA subunit expression was detected at low to moderate levels between PND 0 and PND 56. The uteri of some ewes contained black melanocytes that appear white in dark-field photomicrographs and black in bright-field photomicrographs of in situ hybridization and immunohistochemistry slides; however, these cells are not positive for mRNA or protein.

ßB subunit Expression of ßB subunit mRNA and protein was detected in all endometrial cell types, with the most abundant expression detected in the endometrial LE and GE (Fig. 1B and Table 2). In the myometrium, ßB subunit expression was detected at low levels.

ActRIA, ActRIB, and ActRII

Representative photomicrographs of in situ hybridization and immunohistochemistry results are presented in Figure 2. Patterns of immunoreactive protein expression are summarized in Table 3.



View larger version (122K):
[in this window]
[in a new window]
 
FIG. 2. Expression of ActRs in the neonatal ovine uterus. In situ hybridization and immunohistochemical analysis of ActRIA (A) and ActRII (B) and immunohistochemical analysis of ActRIB (C) in the uterus. Except for ActRIB, representative photomicrographs of in situ hybridization results are presented in bright-field and dark-field illumination (left). Melanocytes (Mel) in the endometrium appear white in the dark-field images and black in bright-field images, but they do not express subunit mRNA. Representative photomicrographs of immunohistochemical results are presented for the upper and lower portions of the uterine wall (right). As a negative control, mouse IgG (mIgG) was substituted for the primary antibody. M, Myometrium; S, stroma. Bars = 50 µm


View this table:
[in this window]
[in a new window]
 
TABLE 3. Distribution and relative abundance of immunoreactive ActRIA, ActRIIA/B, and ActRIB protein in the neonatal uterus.a

ActRIA In the endometrium (Fig. 2A and Table 3), expression of ActRIA mRNA and protein was detected in all cell types but was most abundant in the endometrial LE and GE on PNDs 0, 7, and 56. In the myometrium, ActRIA was detected at low levels.

ActRII In the endometrium, ActRII mRNA and protein was detected in all cell types but was most abundant in the endometrial LE and ductal GE (Fig. 2B and Table 3). The antibody used for immunohistochemistry detects both ActRIIA and ActRIIB (R&D Systems). In the developing coiled and branched glands and myometrium, expression of ActRIIA/B protein was low.

ActRIB A partial cDNA for ActRIB was detected abundantly in total RNA isolated from the neonatal ovary but at extremely low amounts in the neonatal ovine uterus (data not shown). The low abundance of ActRIB mRNA was below the detectable limits of the in situ hybridization procedure (data not shown). In the endometrium, ActRIB protein was detected in all cell types but was most abundant in the endometrial LE and ductal GE (Fig. 2C and Table 3). In the developing coiled and branched uterine glands and myometrium, expression of ActRIB protein was low, except on PND 56.

Follistatin

Representative photomicrographs of in situ hybridization and immunohistochemistry results are presented in Figure 3. Patterns of immunoreactive protein expression are summarized in Table 4.



View larger version (143K):
[in this window]
[in a new window]
 
FIG. 3. Expression of follistatin in the neonatal ovine uterus. In situ localization of follistatin mRNA in the uterus is presented in bright-field and dark-field illumination (left). Representative photomicrographs of immunohistochemical results are presented for the upper and lower portions of the uterine wall (right). As a negative control, mouse IgG (mIgG) was substituted for the primary antibody. M, Myometrium; S, stroma. Bars = 50 µm


View this table:
[in this window]
[in a new window]
 
TABLE 4. Distribution and relative abundance of immunoreactive follistatin protein in the neonatal uterus.a

In the neonatal uterus (Fig. 3 and Table 4), immunoreactive follistatin protein was abundant in the endometrial LE on PND 0 and PND 7. In contrast, only low levels of follistatin mRNA were detected in the endometrial stroma on PNDs 0 and 14. On PND 7 and PND 14, expression of follistatin protein was also detected in the emerging GE. However, by PND 21, follistatin expression was no longer detectable in the endometrial GE but had increased in the periglandular stroma and myometrium. Between PND 21 and PND 56, moderate to abundant levels of follistatin were detected in the endometrial stroma and myometrium but not in the developing GE.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study, expression of the ßA and ßB subunits, but not of the inhibin {alpha} subunit, was detected in the endometrial LE and developing GE as well as in the uterine stroma and myometrium. Therefore, biologically active activins A, B, and/or AB likely are formed in the neonatal ovine uterus without interference from the inhibin {alpha} subunit. Expression of both ActRI and ActRII was detected in the endometrial LE and GE as well as in the stroma and myometrium. Although inhibin {alpha} subunit was not detected in the neonatal uterus, follistatin was expressed in the neonatal uterus, with highest levels detected in the endometrial stroma and myometrium between PND 21 and PND 56. Collectively, the results of the present study support our working hypothesis that the follistatin-activin system is present in the uterus and may have a regulatory role in postnatal uterine development during the critical period of coiling and branching morphogenesis of the endometrial glands.

Components of the activin-follistatin system have been studied in various mutant mice [35]. However, widespread expression of activins in multiple organs and redundancy in the activin system have hampered efforts to determine the specific role of this system in the development and physiology of most organs. Female mice lacking the ßB subunit display abnormal mammary ductal elongation and alveolar morphogenesis during puberty and pregnancy [36]. Although mouse models indicate a vital role for activins in organ development, activins generally appear to inhibit epithelial morphogenesis [28, 37]. In these developing organs, activins disrupt normal lobulation patterns of epithelial growth in the developing pancreas and salivary gland [11]. In contrast, other studies indicate that activin may trigger digestion of the extracellular matrix at the site of a new branch and that activin A may cause breakdown of the extracellular matrix throughout the epithelium in the kidney [38]. However, activin A inhibits branching and elongation of epithelia in cultured mouse pancreatic rudiments, thereby blocking development of the exocrine pancreas [11]. Addition of exogenous activin A inhibits hepatocyte growth factor (HGF)-induced growth of mammary epithelial cells and tubule formation [16]. Interestingly, HGF and the HGF receptor, c-met, are candidate regulators of postnatal uterine development and adenogenesis in the neonatal ewe [3, 4]. The biological effects of activins are mediated by ActRI and ActRII. In the present study, ActRIA, ActRIB, and ActRII were detected in emerging, proliferating, and branching GE. Activins initially bind to a type II binding receptor, which then recruits and phosphorylates a type I signaling receptor. Two type I receptors are known, ActRIB and ActRIA [3941]. In the present study, ActRII was detected in endometrial LE, GE, and stroma as well as myometrium. In contrast, ActRIA and ActRIB were expressed predominantly in endometrial LE and GE. Overall, the most abundant expression of the ActR subunits was in endometrial LE and GE. In the endometrial GE, expression was most abundant in the developing glands before PND 14 and on PND 56. Available results indicate that activins produced in neonatal ovine uterus may play distinct autocrine and paracrine roles in gland development during the periods of endometrial gland bud differentiation, elongation or tubulogenesis, and branching morphogenesis. The possibility of endocrine effects of these hormones from the ovary must also be considered [32]. Future experiments will explore the roles of activins and their receptors in neonatal ovine endometrial adenogenesis.

In other developing organs and in the endocrine system, the autocrine and paracrine activities of activins can be regulated by follistatin and the inhibin {alpha} subunit [26, 27, 29, 30]. In human endometrium and developing rat prostate, expression of the inhibin {alpha} subunit was not detected [15, 42]. Similarly, inhibin {alpha} subunit mRNA and protein were either absent or below detectable limits in neonatal ovine uterine tissues in the present study. However, follistatin mRNA and protein were readily detected in the neonatal ovine uterus. Between birth and PND 14, follistatin protein was expressed in endometrial LE, GE, and stroma. Interestingly, follistatin mRNA was detected only at low levels in endometrial stroma between PNDs 0 and 14. After PND 14, follistatin expression declined to undetectable levels in endometrial LE and GE and increased in the endometrial stroma and myometrium. As for ActR subunits, these striking spatial changes in follistatin expression are clearly associated with the period of endometrial gland coiling and branching morphogenesis that occurs primarily between PND 14 and PND 56.

Follistatin has been implicated as a regulator of epithelial branching morphogenesis in a number of organs. The expression of follistatin is regulated by various factors, including activins [43]. In Madin-Darby canine kidney (MDCK) cells, epithelial tubulogenesis can be stimulated by HGF or addition of exogenous follistatin [36]. Indeed, stimulation of MDCK cell tubulogenesis by HGF, a stromal cell-derived growth factor expressed during ovine uterine adenogenesis [3], involves suppression of activin A expression [44]. In the developing prostate, follistatin can neutralize the inhibitory effects of exogenous activin A and appears to modulate the rate of branching morphogenesis [15]. A similar effect has been observed in the pancreas [18]. Available results indicate that a carefully orchestrated interplay between activin and follistatin is important for correct epithelial branching morphogenesis and that a similar system likely regulates endometrial gland branching morphogenesis in the neonatal ovine uterus. Indeed, a recent study by our laboratory found that ovariectomy of ewes on PND 7 retarded uterine growth as well as coiling and branching morphogenesis of endometrial glands on PND 56 [32]. In that study, the normal patterns of activin-follistatin system expression observed in the present study were significantly altered in the uterus of ovariectomized ewes. Given that the neonatal ovine ovary develops numerous antral follicles that express all the components necessary to produced activin, follistatin, and inhibin [32, 45, 46], these factors likely are secreted into the circulatory system and act in an endocrine fashion to influence uterine development by the activin-follistatin system [32]. Results from the present study support the working hypothesis that the activin-follistatin system is present in the developing neonatal ovine uterus and is involved in endometrial gland morphogenesis. Specifically, activins are expressed predominantly in the developing endometrial epithelium of the uterus. Between PND 0 and PND 14, activins may be involved in GE bud formation and tubulogenesis. After PND 14, follistatin expression decreases in the LE and developing GE and increases in the stroma and myometrium. During this period of coiling and branching morphogenesis, follistatin may bind epithelial activin subunits and prevent the inhibitory effects of activins on epithelial growth and differentiation. Future experiments will be directed toward understanding the role of the activin-follistatin system in branching morphogenesis of the endometrial glands during development of the neonatal ovine uterus.


    ACKNOWLEDGMENTS
 
The authors thank Mr. Kendrick LeBlanc for assistance with animal husbandry and surgery.


    FOOTNOTES
 
1 Supported by NIH grant HD38274 and grant P30 ES09106. Back

2 Correspondence: Thomas E. Spencer, Center for Animal Biotechnology and Genomics, 442 Kleberg Center, 2471 TAMU, Texas A&M University, College Station, TX 77843-2471. FAX: 979 862 2662; tspencer{at}ansc.tamu.edu Back

Received: 12 February 2003.

First decision: 21 March 2003.

Accepted: 8 May 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Wiley AA, Bartol FF, Barron DH. Histogenesis of the ovine uterus. J Anim Sci 1987 64:1262-1269
  2. Taylor KM, Gray CA, Joyce MM, Stewart MD, Bazer FW, Spencer TE. Neonatal ovine uterine development involves alterations in expression of receptors for estrogen, progesterone, and prolactin. Biol Reprod 2000 63:1192-1204[Abstract/Free Full Text]
  3. Taylor KM, Chen C, Gray CA, Bazer FW, Spencer TE. Expression of messenger ribonucleic acids for fibroblast growth factors 7 and 10, hepatocyte growth factor, and insulin-like growth factors and their receptors in the neonatal ovine uterus. Biol Reprod 2001 64:1236-1246[Abstract/Free Full Text]
  4. Gray CA, Taylor KM, Bazer FW, Spencer TE. Mechanisms regulating norgestomet inhibition of endometrial gland morphogenesis in the neonatal ovine uterus. Mol Reprod 2000 57:67-78[CrossRef]
  5. Carpenter KD, Gray CA, Noel SD, Gertler A, Bazer FW, Spencer TE. Prolactin regulation of neonatal ovine uterine gland morphogenesis. Endocrinology 2003 144:110-120[Abstract/Free Full Text]
  6. Kennedy JP, Worthington CA, Cole ER. The post-natal development of the ovary and uterus of the Merino lamb. J Reprod Fertil 1974 36:275-282[Medline]
  7. Wimsatt WA. New histological observations on the placenta of the sheep. Am J Anat 1950 87:391-436[CrossRef][Medline]
  8. Stewart MD, Johnson GA, Gray CA, Burghardt RC, Schuler LA, Joyce MM, Bazer FW, Spencer TE. Prolactin receptor and uterine milk protein expression in the ovine endometrium during the estrous cycle and pregnancy. Biol Reprod 2000 62:1779-1789[Abstract/Free Full Text]
  9. Bartol FF, Wiley AA, Floyd JG, Ott TL, Bazer FW, Gray CA, Spencer TE. Uterine differentiation as a foundation for subsequent fertility. J Reprod Fertil Suppl 1999 53:284-300
  10. Gray CA, Bartol FF, Tarleton BJ, Wiley AA, Johnson GA, Bazer FW, Spencer TE. Developmental biology of uterine glands. Biol Reprod 2001 65:1311-1323[Abstract/Free Full Text]
  11. Ritvos O, Tuuri T, Eramaa M, Sainio K, Hilden K, Saxen L, Gilbert SF. Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech Dev 1995 50:229-245[CrossRef][Medline]
  12. Hilden K, Tuuri T, Eramaa M, Ritvos O. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood 1994 83:2163-2170[Abstract/Free Full Text]
  13. Roberts VJ, Barth SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 1994 134:914-923[Abstract]
  14. Tuuri T, Eramaa M, Hilden K, Ritvos O. The tissue distribution of activin ßA- and ßB-subunits and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 1994 78:1521-1524[Abstract]
  15. Cancilla B, Jarred RA, Wang H, Mellor SL, Cunha GR, Risbridger GP. Regulation of prostate branching morphogenesis by activin A and follistatin. Dev Biol 2001 237:145-158[CrossRef][Medline]
  16. Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L. Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res 1996 56:1155-1163[Abstract/Free Full Text]
  17. Zhao Y, Silbajoris R, Young SL. Identification and developmental expression of two activin receptors in baboon lung. Biochem Biophys Res Commun 1996 229:50-57[CrossRef][Medline]
  18. Miralles F, Czernichow P, Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 1998 125:1017-1024[Abstract]
  19. Furukawa M, Eto Y, Kojima I. Expression of immunoreactive activin A in fetal rat pancreas. Endocr J 1995 42:63-68[Medline]
  20. Yamaoka T, Idehara C, Yano M, Matsushita T, Yamada T, Ii S, Moritani M, Hata J, Sugino H, Noji S, Itakura M. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest 1998 102:294-301[Medline]
  21. Maldonado TS, Kadison AS, Crisera CA, Grau JB, Alkasab SL, Longaker MT, Gittes GK. Ontogeny of activin B and follistatin in developing embryonic mouse pancreas: implications for lineage selection. J Gastrointest Surg 2000 4:269-275[CrossRef][Medline]
  22. Blauer M, Wichmann L, Punnonen R, Tuohimaa P. Measurement of activin B in human salivary and localization of activin subunits in rat salivary glands. Biochem Biophys Res Commun 1996 222:230-235[CrossRef][Medline]
  23. Ethier JF, Findlay JK. Roles of activin and its signal transduction mechanisms in reproductive tissues. Reproduction 2001 121:667-675[Abstract]
  24. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med 2002 227:724-752[Abstract/Free Full Text]
  25. Wrana JL, Attisano L. The Smad pathway. Cytokine Growth Factor Rev 2000 11:5-13[CrossRef][Medline]
  26. Xu J, McKeehan K, Matsuzaki K, Mckeehan WL. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 1995 270:6308-6313[Abstract/Free Full Text]
  27. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A 1998 95:9337-9342[Abstract/Free Full Text]
  28. Ball EM, Risbridger GP. Activins as regulators of branching morphogenesis. Dev Biol 2001 238:1-12[CrossRef][Medline]
  29. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science 1990 247:835-838
  30. De Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijden-van Raaij AJ. Follistatin neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 1996 116:105-114[CrossRef][Medline]
  31. Phillips DJ, de Kretser DM. Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 1998 19:287-322[CrossRef][Medline]
  32. Carpenter KD, Hayashi K, Spencer TE. Ovarian regulation of endometrial gland morphogenesis and the activin-follistatin system in the neonatal ovine uterus. Biol Reprod 2003 69:851-860[Abstract/Free Full Text]
  33. Spencer TE, Gray CA, Joyce MM, Jenster G, Wood CG, Bazer FW, Wiley AA, Bartol FF. Discovery and characterization of endometrial epithelial messenger ribonucleic acids using the ovine uterine gland knockout model. Endocrinology 1999 140:4070-4080[Abstract/Free Full Text]
  34. Spencer TE, Ing NH, Ott TL, Mayes JS, Becker WC, Watson GH, Mirando MA, Bazer FW. Intrauterine injection of ovine interferon-{tau} alters oestrogen receptor and oxytocin receptor expression in the endometrium of cyclic ewes. J Mol Endocrinol 1995 15:203-220[Abstract]
  35. Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, Bradley A. Functional analysis of activins during mammalian development. Nature 1995 374:354-356[CrossRef][Medline]
  36. Robinson GW, Hennighausen L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 1997 124:2701-2708[Abstract]
  37. Mather JP, Moore A, Li RH. Activins, inhibins and follistatin: further thoughts on a growing family of regulators. Proc Exp Biol Med 1997 215:209-222[Abstract]
  38. Maeshima A, Nojima Y, Kojima I. The role of the activin-follistatin system in the developmental and regeneration processes of the kidney. Cytokine Growth Factor Rev 2001 12:289-298[CrossRef][Medline]
  39. Mathews LS. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 1994 15:310-325[CrossRef][Medline]
  40. Massague J, Chen YG. Controlling TGF-ß signaling. Genes Dev 2000 14:627-644[Free Full Text]
  41. Chen W, Woodruff TK, Mayo KE. Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and Smad proteins. Endocrinology 2000 141:1263-1272[Abstract/Free Full Text]
  42. Otani T, Minami S, Kokawa K, Shikone T, Yamoto M, Nakano R. Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 1998 91:685-692[Abstract]
  43. Ying SY, Zhang Z, Furst B, Batres Y, Huang G, Li G. Activins and activin receptors in cell growth. Proc Soc Exp Biol Med 1997 214:114-122[Abstract]
  44. Maeshima A, Zhang YQ, Furukawa M, Naruse T, Kojima I. Hepatocyte growth factor induces branching tubulogenesis in MDCK cells by modulating the activin-follistatin system. Kidney Int 2000 58:1511-1522[CrossRef][Medline]
  45. Braw-Tal R. Expression of mRNA for follistatin and inhibin/activin subunits during follicular growth and atresia. J Mol Endocrinol 1994 13:253-264[Abstract]
  46. Braw-Tal R, Yossefi S, Zenou A, Bor A. Differential expression pattern of inhibin {alpha} and ßA subunits in the ovaries of postnatal and prepubertal lambs. Reprod Fertil Dev 1997 9:825-832[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
P. Ciarmela, E. Wiater, and W. Vale
Activin-A in Myometrium: Characterization of the Actions on Myometrial Cells
Endocrinology, May 1, 2008; 149(5): 2506 - 2516.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Manikkam, R. C. Thompson, C. Herkimer, K. B. Welch, J. Flak, F. J. Karsch, and V. Padmanabhan
Developmental Programming: Impact of Prenatal Testosterone Excess on Pre- and Postnatal Gonadotropin Regulation in Sheep
Biol Reprod, April 1, 2008; 78(4): 648 - 660.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K. Hayashi, A. R O'Connell, J. L Juengel, K. P McNatty, G. H Davis, F. W Bazer, and T. E Spencer
Postnatal uterine development in Inverdale ewe lambs
Reproduction, March 1, 2008; 135(3): 357 - 365.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Hayashi and T. E. Spencer
WNT Pathways in the Neonatal Ovine Uterus: Potential Specification of Endometrial Gland Morphogenesis by SFRP2
Biol Reprod, April 1, 2006; 74(4): 721 - 733.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Hayashi and T. E. Spencer
Estrogen Disruption of Neonatal Ovine Uterine Development: Effects on Gene Expression Assessed by Suppression Subtraction Hybridization
Biol Reprod, October 1, 2005; 73(4): 752 - 760.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K. Hayashi, K. D Carpenter, T. H Welsh Jr, R. C Burghardt, L. J Spicer, and T. E Spencer
The IGF system in the neonatal ovine uterus
Reproduction, March 1, 2005; 129(3): 337 - 347.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Hayashi, K. D. Carpenter, and T. E. Spencer
Neonatal Estrogen Exposure Disrupts Uterine Development in the Postnatal Sheep
Endocrinology, July 1, 2004; 145(7): 3247 - 3257.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. D. Carpenter, K. Hayashi, and T. E. Spencer
Ovarian Regulation of Endometrial Gland Morphogenesis and Activin-Follistatin System in the Neonatal Ovine Uterus
Biol Reprod, September 1, 2003; 69(3): 851 - 860.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/3/843    most recent
biolreprod.103.016287v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, K.
Right arrow Articles by Spencer, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, K.
Right arrow Articles by Spencer, T. E.
Agricola
Right arrow Articles by Hayashi, K.
Right arrow Articles by Spencer, T. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS